info icon

This is a non-core endpoint: only basic statistics are computed.

See its core counterpart C3_GLIOMIX_EXALLC for full statistics.

Brain mixed glioma

C3_GLIOMIX

oligodendroglioma: A well-differentiated (WHO grade II), diffusely infiltrating neuroglial tumor, typically located in the cerebral hemispheres. It is composed predominantly of cells which morphologically resemble oligodendroglia. The neoplastic cells have rounded homogeneous nuclei and, on paraffin sections, a swollen, clear cytoplasm ('honeycomb' appearance). (Adapted from WHO)

Suggest a new description

Endpoint definition

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

  • HLP_C3_GLIOMIX
48

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Cause of death: ICD-10 C71
  • Cause of death: ICD-9 191
  • Cause of death: ICD-8 191
  • Cancer registry: Topography ICD-O-3 C71
  • Cancer registry: Morphology ICD-O-3 9382
  • Cancer registry: Behaviour codes 3

2 out of 7 registries used, show all original rules.

48

4. Check minimum number of events

None

48

5. Include endpoints

48

6. Filter based on genotype QC (FinnGen only)

48

Control definitions (FinnGen only)

Control conditions
not HLP_C3_GLIOMIX

Extra metadata

Level in the ICD hierarchy
C
First used in FinnGen datafreeze
DF8

Similar endpoints

List of similar endpoints to Brain mixed glioma based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 48 19 29
Unadjusted period prevalence (%) 0.01 0.01 0.01
Median age at first event (years) 40.97 38.70 42.47

-FinnGen-

Age distribution of first events

01040506002468101214161820AgeIndividuals

-FinnGen-

Year distribution of first events

19701975198019852005201020230246810121416182022242628YearIndividuals

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

No data available

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
24
38
11.63
16.35
4.9
8.4
0.28
1.77
mmol/l
1.52
17
28
21
34
10.20
13.80
1.1
1.3
—
—
—
0
0
14
19
9.99
10.29
6.4
7.5
23.86
25.61
mmol/l
0.86
14
19
26
90
5.12
7.34
14.3
10.3
—
—
—
0
0
27
114
4.13
5.55
1.8
2.3
—
—
—
0
0
39
226
4.86
5.21
16.8
11.8
3.01
3.97
e9/l
3.63
34
196
30
147
3.78
4.77
12.7
11.0
0.00
0.00
e9/l
0.42
25
119
28
142
3.33
4.02
3.3
1.8
—
—
—
0
0
7
10
7.96
3.49
2.0
3.5
—
—
—
0
0
33
197
3.16
3.40
12.5
7.8
0.15
0.18
e9/l
0.52
28
178
9
32
3.22
2.13
8.8
7.6
—
—
—
0
0
7
156
0.36
2.05
1.6
2.3
—
—
—
0
0
5
130
0.31
2.03
3.8
2.9
48.60
55.08
u/l
—
5
123
31
221
2.14
1.67
7.0
5.0
6.52
6.58
mmol/l
0.05
31
196
0
44
0.00
1.61
0.0
1.8
—
—
—
0
0
29
366
0.48
1.59
2.2
4.2
5.56
5.80
mmol/l
0.39
24
341
20
124
2.05
1.53
14.0
6.5
—
—
—
0
0
8
152
0.43
1.49
3.5
2.8
—
—
—
0
0
0
41
0.00
1.39
0.0
1.5
—
—
—
0
0
6
24
2.71
1.35
3.0
9.8
8.93
8.61
mmol/l
—
6
24
5
100
0.44
1.04
1.6
3.0
64865.60
356.60
umol/l
—
5
87
15
95
1.84
1.03
4.6
4.5
—
7.41
—
0
22
19
256
0.57
1.02
2.8
3.8
—
—
—
0
0
0
28
0.00
1.01
0.0
1.1
—
—
—
0
0
5
95
0.47
0.90
1.6
3.4
—
—
—
0
0
0
27
0.00
0.80
0.0
2.9
—
5.07
—
0
27
5
23
2.31
0.79
4.0
5.3
—
—
—
0
0
43
451
0.55
0.65
29.1
18.3
92.51
90.68
fl
2.07
43
446
43
451
0.55
0.65
29.3
18.4
138.37
139.46
g/l
0.19
43
446
43
451
0.55
0.65
28.8
18.2
31.23
30.36
pg
2.51
43
446
43
451
0.55
0.65
29.1
18.3
4.49
4.60
e12/l
0.66
43
440
43
451
0.55
0.65
29.1
18.5
5.67
6.55
e9/l
3.08
43
440
43
450
0.57
0.63
29.1
18.4
222.30
248.65
e9/l
2.44
43
440
0
21
0.00
0.61
0.0
3.9
—
—
—
0
0
0
21
0.00
0.61
0.0
4.7
—
134.33
—
0
21
6
94
0.59
0.48
1.3
1.3
—
—
—
0
0
41
430
0.68
0.47
22.9
14.0
70.93
77.61
umol/l
1.60
41
430
0
18
0.00
0.40
0.0
2.5
—
0.81
—
0
18
0
18
0.00
0.40
0.0
2.5
—
1.48
—
0
18
0
18
0.00
0.40
0.0
5.6
—
25.08
—
0
18
11
81
1.46
0.40
2.3
5.1
—
—
—
0
0
5
76
0.62
0.39
2.8
2.4
—
—
—
0
0
5
78
0.60
0.39
1.2
1.7
25.20
24.35
nmol/l
—
5
66
6
44
1.41
0.36
1.0
1.3
—
—
—
0
0
6
45
1.38
0.35
1.2
2.1
488.33
387.50
nmol/l
—
6
38
40
416
0.77
0.29
13.5
11.1
—
—
—
0
0
42
400
1.40
0.26
18.6
13.5
139.45
139.62
mmol/l
0.13
42
394
6
84
0.67
0.26
2.8
3.2
—
1.02
—
0
8
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
2.0
—
23.93
—
0
10
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
2.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.6
—
228.17
—
0
6
0
12
0.00
0.21
0.0
2.1
—
8.29
—
0
12
0
13
0.00
0.21
0.0
2.5
—
691.80
—
0
5
0
13
0.00
0.21
0.0
3.5
—
—
—
0
0
42
403
1.34
0.17
17.6
13.5
3.91
3.97
mmol/l
0.75
42
396
8
98
0.78
0.15
2.4
2.5
—
—
—
0
0
25
266
0.87
0.11
2.1
3.5
—
—
—
0
0
5
44
1.15
0.10
2.2
3.0
21.24
12.78
umol/l
—
5
38
8
92
0.84
0.07
1.0
1.9
—
—
—
0
0
8
92
0.84
0.07
3.6
3.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.5
—
55.88
—
0
8
0
8
0.00
0.00
0.0
4.6
—
3.48
—
0
8
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
0
7
0.00
0.00
0.0
4.9
—
—
—
0
0
6
64
0.93
0.00
1.3
2.5
486.33
553.82
mosm/kgh2o
—
6
55
0
7
0.00
0.00
0.0
5.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
2.8
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
0.00
0.0
2.3
—
5.17
—
0
7
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
91.64
—
0
5
9
89
1.01
0.00
4.4
6.3
—
—
—
0
0
0
5
0.00
0.00
0.0
5.6
—
8.58
—
0
5
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
12.4
—
1285.80
—
0
5
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
0
5
0.00
0.00
0.0
5.2
—
1.30
—
0
5
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
6.2
—
—
—
0
0
0
5
0.00
0.00
0.0
5.6
—
1.76
—
0
5
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
7
73
0.95
0.00
1.6
2.1
22.00
2.13
e6/l
—
7
67
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
10.4
—
848.80
—
0
5
0
8
0.00
0.00
0.0
4.9
—
54.63
—
0
8
0
9
0.00
0.00
0.0
2.1
—
7.89
—
0
9
0
7
0.00
0.00
0.0
2.3
—
10.46
—
0
7
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.8
—
64.80
—
0
6

Mortality – FinRegistry

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

Index endpoint: C3_GLIOMIX – Brain mixed glioma

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).